Contact us

Adamas Pharmaceuticals presents positive clinical data for ADS-5102

Share on facebook
Share on twitter
Share on linkedin

ADAMAS PHARMACEUTICALS PRESENTS POSITIVE CLINICAL DATA FOR ADS-5102, A TREATMENT FOR LEVODOPA-INDUCED DYSKINESIA, AT THE WORLD PARKINSON’S CONGRESS

  • en
  • cn

    • English

    • English
    • Chinese

    © 2021- edbi. All rights reserved.